The potential rescheduling of cannabinoids, particularly at the federal level, is generating considerable buzz within the market. A shift away from Schedule I status, often viewed as outdated and hindering progress, https://echobookmarks.com/story20728722/marijuana-rescheduling-a-growth-catalyst